Bone morphogenetic protein-2 application by a poly(D,L-lactide)-coated interbody cage: in vivo results of a new carrier for growth factors

被引:49
作者
Kandziora, F [1 ]
Bail, H [1 ]
Schmidmaier, G [1 ]
Schollmeier, G [1 ]
Scholz, M [1 ]
Knispel, C [1 ]
Hiller, T [1 ]
Pflugmacher, R [1 ]
Mittlmeier, T [1 ]
Raschke, M [1 ]
Haas, NP [1 ]
机构
[1] Humboldt Univ, Klinikum Charite, D-13353 Berlin, Germany
关键词
cervical spine; bone morphogenetic protein; interbody fusion; poly(D; L-lactide); growth factor; sheep;
D O I
10.3171/spi.2002.97.1.0040
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. Growth factors such as bone morphogenetic protein-2 (BMP-2) have been proven to promote spine fusion and to overcome the disadvantages of an autologous bone graft. The optimum method to deliver such growth factors remains a matter of discussion. The purpose of this study was to determine the safety and efficacy of a new poly(D,L-lactide) (PDLLA) carrier system for BMP-2 and to compare this carrier system with a collagen sponge carrier in a sheep cervical spine interbody fusion model. Methods. Thirty-two sheep underwent C3-4 discectomy and fusion: Group 1, titanium cage (eight animals); Group 2, titanium cage coated with a PDLLA carrier (eight animals); Group 3, titanium cage coated with a PDLLA carrier including BMP-2 (150 pig) (eight animals); and Group 4, titanium cage combined with a collagen sponge carrier including BMP-2 (150 mug) (eight animals). Blood samples, body weight, and temperature were assessed. Radiographs were obtained pre- and postoperatively and after 1, 2, 4, 8, and 12 weeks. At the same time points, disc space height, intervertebral angle, and lordosis angle were measured. After the sheep were killed 12 weeks postoperatively, flexion-extension radiography was performed to evaluate fusion sites. Quantitative computerized tomography scans were obtained to assess bone mineral density (BMD), bone mineral content (BMC), and bone callus volume (BCV). Biomechanical testing was performed in flexion, extension, axial rotation, and lateral bending. Stiffness, range of motion, neutral, and elastic zone were determined. Histomorphological and -morphometrical analyses were performed, and polychrome sequential labeling was used to determine the timeframe of new bone formation. There were no differences among the groups concerning blood counts, body weight, and temperature. Compared with the noncoated cages, all PDLLA-coated cages showed significantly higher values for BMD of the callus, as well as slightly higher values for BMC, BCV, and the bone volume/total volume ratio. In comparison with the cage-alone group, the BMP-2 groups showed significantly higher values for BMD and biomechanical stiffness. Histomorphological, -morphometrical, and polychrome sequential labeling analyses demonstrated greater progression of callus formation in the BMP-2 groups than in any other group. Compared with BMP-2 delivered using a collagen sponge carrier, BMP-2 application with a PDLLA carrier resulted in a higher BCV and a greater progression of interbody callus formation in the histomorphometrical analysis. Conclusions. The use of cervical spine interbody fusion cages coated with PDLLA as a delivery system for growth factors was effective. In this 12-week follow-up study, the PDLLA coating showed no adverse effects. The slight but not significant positive effect of the PDLLA carrier on interbody fusion might be a result of the degradation process of the biodegradable carrier. Compared with collagen sponge delivery of BMP-2, the PDLLA-coated interbody cages significantly increased the results of interbody bone matrix formation. In this new combination (implant + PDLLA + growth factor) the cage represents a "real fusion" cage, because it not only serves as a mechanical device for spinal fixation but also as a local drug delivery system.
引用
收藏
页码:40 / 48
页数:9
相关论文
共 45 条
  • [1] BMP-2 for intramuscular bone induction - Effect in squirrel monkeys is dependent on implantation site
    Aspenberg, P
    Turek, T
    [J]. ACTA ORTHOPAEDICA SCANDINAVICA, 1996, 67 (01): : 3 - 6
  • [2] Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate
    Boden, SD
    Martin, GJ
    Morone, MA
    Ugbo, JL
    Moskovitz, PA
    [J]. SPINE, 1999, 24 (12) : 1179 - 1185
  • [3] Boden SD, 1998, J SPINAL DISORD, V11, P95
  • [4] The use of rhBMP-2 in interbody fusion cages - Definitive evidence of osteoinduction in humans: A preliminary report
    Boden, SD
    Zdeblick, TA
    Sandhu, HS
    Heim, SE
    [J]. SPINE, 2000, 25 (03) : 376 - 381
  • [5] RESORPTION RATE, ROUTE OF ELIMINATION, AND ULTRASTRUCTURE OF IMPLANT SITE OF POLYLACTIC ACID IN ABDOMINAL-WALL OF RAT
    BRADY, JM
    CUTRIGHT, DE
    MILLER, RA
    BATTISTONE, GC
    HUNSUCK, EE
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1973, 7 (02): : 155 - 166
  • [6] THE ANTERIOR SURGICAL APPROACH TO THE CERVICAL-SPINE - THE CLOWARD PROCEDURE - PAST, PRESENT, AND FUTURE - THE PRESIDENTIAL GUEST LECTURE, CERVICAL-SPINE RESEARCH SOCIETY
    CLOWARD, RB
    [J]. SPINE, 1988, 13 (07) : 823 - 827
  • [7] CUTRIGHT DE, 1971, J ORAL SURG, V29, P393
  • [8] Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine - A comparison of three dosages and two carriers
    David, SM
    Gruber, HE
    Meyer, RA
    Murakami, T
    Tabor, OB
    Howard, BA
    Wozney, JM
    Hanley, EN
    [J]. SPINE, 1999, 24 (19) : 1973 - 1979
  • [9] Fischgrund JS, 1997, J SPINAL DISORD, V10, P467
  • [10] Local effects of transforming growth factor-β1 on rat calvaria:: Changes depending on the dose and the injection site
    Fujimoto, R
    Tanizawa, T
    Nishida, S
    Yamamoto, N
    Soshi, S
    Endo, N
    Takahashi, HE
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 1999, 17 (01) : 11 - 17